INGREDION INCORPORATED (INGR) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | Research and Development Expense |
| Revenue | 7.21B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | (m) | |
| Operating income | 860.00M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $7.21B | (m) | $860.00M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $7.20B | (m) | $943.00M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $71.00M | $7.22B | (m) | $1.02B | (m) | 0.98% | (m) | (m) | (m) |
| 2025-09-30 | (m) | $7.26B | (m) | $958.00M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $7.32B | (m) | $977.00M | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $7.36B | (m) | $946.00M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $67.00M | $7.43B | (m) | $883.00M | (m) | 0.90% | (m) | (m) | (m) |
| 2024-09-30 | (m) | $7.55B | (m) | $923.00M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $7.71B | (m) | $868.00M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $7.91B | (m) | $879.00M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $63.00M | $8.16B | (m) | $957.00M | (m) | 0.77% | (m) | (m) | (m) |
| 2023-09-30 | (m) | $8.23B | (m) | $912.00M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $8.22B | (m) | $881.00M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $8.19B | (m) | $843.00M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $52.00M | $7.95B | (m) | $762.00M | (m) | 0.65% | (m) | (m) | (m) |
| 2022-09-30 | (m) | $7.71B | (m) | $691.00M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $7.45B | (m) | $681.00M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $7.17B | (m) | $690.00M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $43.00M | $6.89B | (m) | $310.00M | (m) | 0.62% | (m) | (m) | (m) |
| 2021-09-30 | (m) | $6.73B | (m) | $387.00M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $6.47B | (m) | $368.00M | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $6.06B | (m) | $259.00M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $5.99B | (m) | $582.00M | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $5.94B | (m) | $589.00M | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $6.01B | (m) | $601.00M | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $6.22B | (m) | $656.00M | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $6.21B | (m) | $664.00M | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | $5.74B | (m) | $652.00M | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $5.73B | (m) | $642.00M | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $5.79B | (m) | $667.00M | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $5.84B | (m) | $703.00M | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) | $753.00M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | $829.00M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | $846.00M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | $842.00M | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | $828.00M | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | $816.00M | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | $803.00M | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | (m) | $808.00M | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) | $792.00M | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | $746.00M | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | $720.00M | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | (m) | $660.00M | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | (m) | (m) | $604.90M | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | $608.10M | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | $598.20M | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | $581.00M | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | (m) | (m) | $624.00M | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | $582.70M | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | $560.20M | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | $613.00M | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | $637.50M | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | $669.40M | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | $682.10M | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | $6.53B | (m) | $668.00M | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | $6.44B | (m) | $648.90M | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | $6.38B | (m) | $622.50M | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | $6.33B | (m) | $604.60M | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $6.22B | (m) | $671.00M | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | $6.08B | (m) | $606.80M | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | $5.47B | (m) | $553.00M | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | $4.89B | (m) | $494.60M | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $4.37B | (m) | $339.00M | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | $3.67B | (m) | $153.00M | (m) | (m) | (m) | (m) | (m) |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | $3.94B | (m) | $434.00M | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Post Holdings, Inc. (POST) | United States | $3.260B | 13.64 |
| Freshpet, Inc. (FRPT) | United States | $2.801B | |
| GENERAL MILLS INC (GIS) | United States | $18.629B | -24.78 |